DDO and schizophrenia: In particular, Nuzzo et al. reported that lower levels of D-Asp in the dorsolateral PFC (DLPFC) of patients with schizophrenia are associated to significantly increased DDO enzymatic activity, thus suggesting alterations in D-Asp metabolism in this psychiatric disorder18.